weekly semaglutide dose The FDA has approved a new higher (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing A new study suggests GLP-1s

Since 2020, the number of prescriptions made for these drugs has tripled, and its estimated that 12% of Americans have used these medications

Additionally, the gastrointestinal side effects of Rybelsus may cause dehydration, which could potentially lead to acute kidney injury, particularly in those with pre-existing renal impairment

GLP-1RA Breast Cancer Survival Background BC is the most common cancer among females in the United States (US), and pre-existing conditions like type 2 diabetes (T2D) and obesity elevate the risk of reduced survival, disease progression, and recurrence

The field is rapidly moving beyond single-target GLP-1 agonism: dual and triple agonists, combining GLP-1 with receptors for GIP and/or glucagon, are designed to produce larger weight loss and beneficial metabolic effects